Home›Companies›Biotech & Pharma›Promaxo

Promaxo, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 10, 2024·Suggest an edit

About Promaxo

Promaxo is a private company based in Oakland, California. It has reported $60,878,725 raised in four offerings on Form D since September 2017. Its chief executive is Amit Vohra.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 25, 2024Apr 8, 2024amended Jul 10, 2024$41,939,728of $57.3M target163$257KEquityRule 506(b)Form D/A ↗1 earlier filing
Dec 31, 2020Jan 7, 2021$4,177,009of $4.9M target4$1.0MEquityRule 506(b)Form D ↗
May 15, 2020May 21, 2020$10,971,981of $30.6M target69$159KEquityRule 506(b)Form D ↗
Sep 12, 2017Sep 22, 2017$3,790,007of $7.5M target10$379KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Total, four offerings$60,878,725

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Promaxo's Form D filed Jul 10, 2024.

Amit Vohra
Amit Vohra
CEO and director
Also CEO and director at Neuro42 and Promaxo.
Michael Bartholomew
Michael Bartholomew
Executive officer and director
Also a secretary of the board at Promaxo.
JC
DH
Derek Hennecke
Director
Also a director at Promaxo.
DC
Dushyant Chipalkatty
Director
Also a director at Promaxo.
DK
Dinesh Kumar
Executive officer

Earlier filings also listed Dan McCormick (director, last listed Jan 2021).

Sources

  1. SECPromaxo, Inc. Form D, filed Apr 8, 2024
  2. SECPromaxo, Inc. filing history